Author

Yeaji Kim

MetroHealthORCID 0000-0002-9349-1763Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Khalid Sossey‐AlaouiiD· 2 shared Aurelio LoricoiD· 1 shared Bin Su· 1 shared Kristen Weber Bonk· 1 shared Mark F. SantosiD· 1 shared Ruth A. KeriiD· 1 shared Tyler Biebighauser· 1 shared Wei Wang· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Khalid Sossey‐AlaouiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 10, 2026

The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple-negative breast cancer tumors

Wei Wang, Yeaji Kim, Xiaotong Zhao…·Khalid Sossey‐Alaoui

This study shows that SU056, a YB1 inhibitor, suppresses TNBC growth and metastasis by targeting the Rb pathway, with enhanced efficacy when combined with CDK4/6 inhibition.

DOI 10.64898/2026.09.05.749600

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 15, 2026

Nuclear translocation of phosphorylated YB-1 via small extracellular vesicles contributes to the malignant phenotype of triple negative breast cancer

Mark F. Santos, Yeaji Kim, Zhimin Feng…·Khalid Sossey‐Alaoui

This study shows that phosphorylated YB-1 in small extracellular vesicles promotes metastasis in TNBC by translocating to the nucleus of recipient cells.

DOI 10.64898/2026.07.14.738446

mouseproteomics

𝕏 PostBluesky